Antiretroviral therapy (ART) in the management of HIV-1 infection is associated with significant reductions in morbidity and mortality.1 Until recently, access to such life-saving therapy in sub-Saharan Africa, a region that bears 70 % of the HIV-1 burden,2 has bee
Despite the enormous progress made in scaling up antiretroviral therapy (ART) in sub-Saharan Africa,...
Among 35 million people living with the human immunodeficiency virus (HIV) in 2013, only 37% had acc...
The availability and use of antiretroviral therapy (ART) has increased considerably in Sub-Saharan A...
HIV has become one of the most feared diseases in the world. It has claimed millions of lives, espec...
The introduction of antiretroviral therapy (ART) in middle and low income countries is arguably one ...
Antiretroviral therapy (ART) has transformed the lives of individuals with HIV in many parts of sub-...
Scientists from the WHO have presented a theoretical mathematical model of the potential impact of u...
Since 2003, great strides have been made in the provision of life-saving antiretroviral therapy (ART...
Human immunodeficiency virus (HIV) remains an important cause of hospitalization and death in low- a...
Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because m...
Two-thirds of the world's HIV-infected people live in sub-Saharan Africa, and more than 1.5 million ...
In the early 2000s, the pages of medical journals were filled with (often rancorous) debates about t...
Combination antiretroviral therapy (ART) has greatly improved the prognosis of HIV-infected individu...
High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Afr...
Direct measurement of antiretroviral treatment (ART) program indicators essential for evidence-based...
Despite the enormous progress made in scaling up antiretroviral therapy (ART) in sub-Saharan Africa,...
Among 35 million people living with the human immunodeficiency virus (HIV) in 2013, only 37% had acc...
The availability and use of antiretroviral therapy (ART) has increased considerably in Sub-Saharan A...
HIV has become one of the most feared diseases in the world. It has claimed millions of lives, espec...
The introduction of antiretroviral therapy (ART) in middle and low income countries is arguably one ...
Antiretroviral therapy (ART) has transformed the lives of individuals with HIV in many parts of sub-...
Scientists from the WHO have presented a theoretical mathematical model of the potential impact of u...
Since 2003, great strides have been made in the provision of life-saving antiretroviral therapy (ART...
Human immunodeficiency virus (HIV) remains an important cause of hospitalization and death in low- a...
Evaluation of antiretroviral treatment (ART) programmes in sub-Saharan Africa is difficult because m...
Two-thirds of the world's HIV-infected people live in sub-Saharan Africa, and more than 1.5 million ...
In the early 2000s, the pages of medical journals were filled with (often rancorous) debates about t...
Combination antiretroviral therapy (ART) has greatly improved the prognosis of HIV-infected individu...
High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Afr...
Direct measurement of antiretroviral treatment (ART) program indicators essential for evidence-based...
Despite the enormous progress made in scaling up antiretroviral therapy (ART) in sub-Saharan Africa,...
Among 35 million people living with the human immunodeficiency virus (HIV) in 2013, only 37% had acc...
The availability and use of antiretroviral therapy (ART) has increased considerably in Sub-Saharan A...
DOI
Add to ORKG